113 related articles for article (PubMed ID: 34655076)
1. The Role of Pentraxin-3, Fetuin-A and Sirtuin-7 in the Diagnosis of Prostate Cancer.
Güzel Ö; Kösem A; Aslan Y; Asfuroglu A; Balci M; Senel C; Tuncel A
Urol J; 2021 Oct; 19(3):196-201. PubMed ID: 34655076
[TBL] [Abstract][Full Text] [Related]
2. Serum amyloid A, fetuin-A, and pentraxin-3 levels in patients with ischemic stroke: novel prognostic biomarkers?
Sezer S; Uçar F; Ulusoy EK; Erdogan S; Bilen S; Züngün C; Uysal S; Erdemli HK
Turk J Med Sci; 2014; 44(1):16-23. PubMed ID: 25558553
[TBL] [Abstract][Full Text] [Related]
3. Levels of serum pentraxin 3, IL-6, fetuin A and insulin in patients with rheumatoid arthritis.
Tekeoğlu İ; Harman H; Sağ S; Altındiş M; Kamanlı A; Nas K
Cytokine; 2016 Jul; 83():171-175. PubMed ID: 27152709
[TBL] [Abstract][Full Text] [Related]
4. Potential Correlation Between Circulating Fetuin-A and Pentraxin-3 With Biochemical Parameters of Calcification in Hemodialysis Patients.
Hashemi J; Joshaghani HR; Akaberi A; Hesari Z; Ghanbari R; Mohammadzadeh M; Golshan AR
Arch Iran Med; 2017 Dec; 20(12):752-755. PubMed ID: 29664315
[TBL] [Abstract][Full Text] [Related]
5. Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer.
Stallone G; Cormio L; Netti GS; Infante B; Selvaggio O; Fino GD; Ranieri E; Bruno F; Prattichizzo C; Sanguedolce F; Tortorella S; Bufo P; Grandaliano G; Carrieri G
Cancer Res; 2014 Aug; 74(16):4230-8. PubMed ID: 24950910
[TBL] [Abstract][Full Text] [Related]
6. Serum Visfatin, Fetuin-A, and Pentraxin 3 Levels in Patients With Psoriasis and Their Relation to Disease Severity.
Okan G; Baki AM; Yorulmaz E; Doğru-Abbasoğlu S; Vural P
J Clin Lab Anal; 2016 Jul; 30(4):284-9. PubMed ID: 25867925
[TBL] [Abstract][Full Text] [Related]
7. The levels of serum pentraxin3, CRP, fetuin-A, and insulin in patients with psoriasis.
Uysal S; Yılmaz FM; Karatoprak K; Artüz F; Cumbul NU
Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3453-8. PubMed ID: 25491620
[TBL] [Abstract][Full Text] [Related]
8. Serum fetuin-A levels are associated with carotid intima-media thickness in patients with normotensive chronic obstructive pulmonary disease.
Alpsoy S; Akyuz A; Mutlu LC; Oran M; Akkoyun DC; Topcu B; Degirmenci H; Guze S
Cardiol J; 2014; 21(2):191-7. PubMed ID: 23799555
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate reduces inflammation in obese patients with or without type 2 diabetes mellitus via sirtuin 1/fetuin A axis.
Noureldein MH; Abd El-Razek RS; El-Hefnawy MH; El-Mesallamy HO
Diabetes Res Clin Pract; 2015 Sep; 109(3):513-20. PubMed ID: 26105582
[TBL] [Abstract][Full Text] [Related]
10. Association of serum fetuin-A and biochemical parameters in hemodialysis patients.
Haddad M; Tajbakhsh R; Farajollahi M; Qorbani M; Besharat S; Joshaghani HR
Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):769-73. PubMed ID: 24969186
[TBL] [Abstract][Full Text] [Related]
11. Relationship of interleukin-23 with matrix metalloproteinase-9, pentraxin-3, sleep quality and prostate size in benign prostatic hyperplasia.
Navaneethakannan M; Nandeesha H; Sreenivasan SK
Andrologia; 2022 Jun; 54(5):e14387. PubMed ID: 35092070
[TBL] [Abstract][Full Text] [Related]
12. Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients.
Argani H; Ghorbanihaghjo A; Panahi G; Rashtchizadeh N; Safa J; Meimand SM
Clin Biochem; 2012 Jul; 45(10-11):775-9. PubMed ID: 22546644
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic significance of biochemical markers and pentraxin-3 in the differential diagnosis of malign, benign pleural effusion and empyema.
Dongel I; Gokmen AA; Camas HE; Gonen I; Kaya S
J Pak Med Assoc; 2020 May; 70(5):860-864. PubMed ID: 32400742
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum Pentraxin 3 and pro-adrenomedullin levels with acute cholecystitis.
Algin A; Gulacti U; Inan İ; Erdogan MO; Colak S; Sariaydin M
Am J Emerg Med; 2019 Jul; 37(7):1268-1272. PubMed ID: 30245078
[TBL] [Abstract][Full Text] [Related]
15. High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL.
Miyoshi Y; Uemura H; Suzuki K; Shibata Y; Honma S; Harada M; Kubota Y
Andrology; 2017 Mar; 5(2):262-267. PubMed ID: 27813361
[TBL] [Abstract][Full Text] [Related]
16. 12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate.
Signoriello E; Iardino P; Casertano S; De Lucia D; Pucciarelli A; Puoti G; Chiosi E; Lus G
J Neuroimmunol; 2020 Nov; 348():577385. PubMed ID: 32927398
[TBL] [Abstract][Full Text] [Related]
17. Serum pentraxin-3 levels are associated with the severity of metabolic syndrome.
Karakas MF; Buyukkaya E; Kurt M; Motor S; Akcay AB; Karakas E; Buyukkaya Ş; Sen N
Med Princ Pract; 2013; 22(3):274-9. PubMed ID: 23146973
[TBL] [Abstract][Full Text] [Related]
18. Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer.
Sershon PD; Barry MJ; Oesterling JE
Eur Urol; 1994; 25(4):281-7. PubMed ID: 7519989
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the inflammatory biomarkers of metabolic syndrome in adolescents.
Can U; Buyukinan M; Guzelant A; Ugur A; Karaibrahimoglu A; Yabancıun S
J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1277-1283. PubMed ID: 27754964
[TBL] [Abstract][Full Text] [Related]
20. Using pentraxin-3 for diagnosing acute appendicitis and predicting perforation: A prospective comparative methodological study.
Gul VO; Destek S
Ulus Travma Acil Cerrahi Derg; 2020 Jan; 26(1):21-29. PubMed ID: 31942733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
